advanbiomed.com - ADVB Operating profit EBITDA
Advanced Biomed Inc (ADVB) is implementing precision chips for rapid blood-based oncology diagnostics. The EBITDA growth trajectory illustrates operating cash flow volatility, where the 0.00 level records fresh values. Analysis automation via microfluidic systems is replacing manual laboratory labor. However, capital shortages and the pending certification of new platforms create significant financial risks for the issuer.
Advanced Biomed (ADVB) - metric breakdowns and financial figures
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Capital Advanced Biomed Inc|ADVB - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Advanced Biomed Inc.|ADVB - Company Total Debt|Debt to Book Capitalization Ratio Advanced Biomed|ADVB - Company Long-Term Debts|Company Short-Term Debts Advanced Biomed|Immediate Liquidity Ratio advanbiomed.com
- earnings and market ratios statistics:
ADVB - Net Profit|Future Profit Advanced Biomed Inc|ADVB - P/E Multiple|Projected Price to Earnings Ratio Advanced Biomed Inc.|ADVB - PEG Multiple|Enterprise Value to Operating Income Before Depreciation Advanced Biomed|ADVB - Operating profit before deduction of amortization|Earnings per share for the trailing year Advanced Biomed|ADVB - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months advanbiomed.com|ADVB - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Advanced Biomed Inc
Fundamental company valuation:Advanced Biomed Inc (ADVB)
To assess the resilience of Advanced Biomed Inc (ADVB) to market shocks, an analysis of cash flow from operating activities before depreciation and interest is critically important. Historical EBITDA_Co trends reflect the actual ability to generate cash, confirming the effectiveness of the optics and chip supplier audit in ensuring the uninterrupted production of diagnostic systems.
Who Advanced Biomed Inc competes with
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit EBITDA PSNL|Operating profit EBITDA erasca.com (ERAS)|Operating profit EBITDA DCTH (Delcath Systems)|YMAB: Operating profit before amortization|AURA: Operating profit before deduction of amortization|CADL: Profit before payment of interest, taxes and amortization|ARAY: Operating profit EBITDA|SELLAS Life Sciences Group (SLS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Actuate Therapeutics|Operating profit before amortization CTOR (Citius Oncology Inc.)|Operating profit EBITDA HURA|Operating profit before deduction of amortization Protara Tx TARA|Operating profit EBITDA FATE (Fate Therapeutics, Inc.)|Aadi Bioscience, Inc. (WHWK) - Profit before interest, taxes and amortization|TScan - Operating profit EBITDA|CSBR (Champions Oncology) - Operating profit before amortization|XBIT (xbiotech.com) - Operating profit before deduction of amortization|CEL-SCI - Income before deduction of interest, taxes and amortization|OSTX (OS Therapies Incorporated) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization RADX|Operating profit EBITDA ARTV|Operating income before deduction of amortization adlainortye.com|Profit before payment of interest, taxes and amortization Veru Pharma VERU|Tempest Therapeutics Corp (TPST) - Profit before interest, taxes and amortization|XLO - Profit before payment of interest, taxes and amortization|Renovaro Inc. (RENB) - Operating profit before deduction of amortization|MURA: Operating profit EBITDA|Profit before interest, taxes and amortization Kairos Pharma (KAPA)|OKUR (OnKure Therapeutics, Inc.) - Operating profit EBITDA|Operating profit before amortization GDTC (CytoMed)|Operating profit before deduction of amortization CRIS (Curis, Inc.)|APLM (apollomicsinc.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA THAR (Tharimmune)|Operating income before deduction of amortization Genprex Inc. (GNPX)|CLDI - Profit before payment of interest, taxes and amortization|SBFM (sunshinebiopharma.com) - Operating profit before amortization|XBIO: Operating profit EBITDA|Operating profit before deduction of amortization salariuspharma.com|PPBT (Purple Biotech Ltd.) - Operating profit EBITDA|Operating profit EBITDA AON|Operating profit EBITDA BGNE|Checkpoint Therapeutics Inc - Operating profit before amortization|Elevation Oncology - Operating profit before deduction of amortization|iCAD Inc. - Profit before payment of interest, taxes and amortization|Ikena - Operating profit EBITDA|NTBL: Profit before payment of interest, taxes and amortization|VIRX: Operating profit EBITDA|Operating profit before deduction of amortization MorphoSys Corporation|NAYA (NAYA Biosciences) - Operating profit EBITDA|Operating profit EBITDA ascentage.com
